Actavis Group has received approval from FDA to market Propranolol Hydrochloride extended-release capsules.
Ads by Google
AIDS Healthcare Foundation called on Indian generic drug manufacturers to reduce the cost of their second-line antiretroviral drugs.
Applying four cost-reduction strategies to its MedCost health plan saved more than $6.6 million in prescription drug costs.
Endorsement of legislation would allow the purchase of lower-cost, FDA-approved drugs from other nations.
Louisville Metro Department of Public Health and Wellness now has a discount card to help consumers cope with the high price of prescription drugs.
Over 33,000 pharmacy customers cite convenience as one of the top three drivers of pharmacy customer satisfaction along with price and overall professional services.
A survey of veterinary-practices examined challenges they face, how they use compounding pharmacies and the factors they consider when choosing a compounding pharmacy.
Bend Research announced a new initiative to make available Pfizer's drug-delivery technology for improving the clinical value of experimental compounds.
Missouri law allows some health care facilities and pharmaceutical companies to redirect surplus, unused prescription drugs to other facilities.
Publix Super Markets no longer will match a program by Wal-Mart that offers 30-day supplies of 143 generic drugs for $4 per prescription.
IBM launched an electronic pedigree system that will help fight prescription drug counterfeiting.
Miami Herald examined concerns among community pharmacists.
Senate Finance Committee Chair Max Baucus (D-Mont.) and ranking member Chuck Grassley (R-Iowa) last week introduced a bill (S 1947) under which Medicare quality improvement organizations could not conduct investigations of beneficiary complaints about health care providers when they serve as consultants for those providers, The Hill reports (Young, The Hill, 8/8).
A bill would require Medicare prescription drug plans to reimburse pharmacies within 14 days for electronically submitted claims and within 30 days for paper claims.
Legislation Would Require Prescription Drug Makers To Disclose Payments Made To Physicians For Consulting
Chuck Grassley would introduce legislation that would require drug makers to make public payments to any physician who bills Medicare and Medicaid programs.
Los Angeles Times examines the effect of drug manufacturers' marketing techniques on physicians and consumers.
The House to pass a bill that would allow U.S. residents to purchase lower-cost prescription drugs from Canada and other nation.
In an advance toward the long-sought ability to deliver medication directly to diseased tissue, while minimizing side effects and damage to healthy parts of the body, scientists are reporting development of a new dosing system that is controlled by light.
Washington law that allows the district to control prescription drug prices violates federal patent law.
An analysis of Milwaukee County pharmacies shows that about half don't provide prescription labels and instructions in languages other than English, and almost two-thirds are unable to communicate to patients who don't speak English. This makes prescription drug safety usage as high priority concern.
Long-term use of histamine2 receptor antagonists (H2A), one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults. According to an Indiana University School of Medicine and Regenstrief Institute study published in the August issue of the Journal of the American Geriatrics Society, the risk for showing signs of cognitive impairment is 2.5 times greater for patients using these medications long-term.
FDA has accepted for review the submission of the complete response by Jazz Pharmaceuticals for Luvox CR extended-release capsules.
A key benchmark of plan performance -- the use of generic medications -- is higher in Medicare Part D than in the rest of the marketplace.
U.S. District Court Judge ruled that 19 current and former female employees of the pharmaceutical company Novartis Pharmaceuticals can proceed with a class-action lawsuit.
A bill would allow uninsured low- and moderate-income adults to buy drugs at Medicaid prices is a reasonable idea.